Main bronchial reconstruction with sparing of pulmonary parenchyma for benign diseases.
Main bronchial reconstruction is anatomically suitable for benign main bronchial stenosis. But, it has been hardly recommended for operative mortality and morbidity. This study was aimed at providing validity and the proper clinical information of bronchoplasty for benign main bronchial stenosis by reviewing the results we obtained over the last ten years for main bronchial reconstruction operations. We retrospectively reviewed admission and office records. Twenty eight consecutive patients who underwent main bronchoplasty were included. Enrolled patients underwent main bronchial reconstruction for benign disease (tuberculosis in 21, trauma in 4, endobronchial mass in 3). Concomitant procedures with main stem bronchoplasty were performed in 19 patients. There were no incidences of postoperative mortality and significant morbidity. There were 2 cases of retained secretions, and these problems were resolved by bronchoscopy or intubation. All of the patients are still alive without obstructive airway problem. Bronchoplasty should be considered as one of the primary treatment modalities, if it is anatomically feasible.
Chang
Jee Won
JW
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Gangnam-Gu, Seoul, Korea.
Choi
Yong Soo
YS
Kim
Kwanmien
K
Shim
Young Mog
YM
Lee
Kyung Soo
KS
Kim
Ho Joong
HJ
Kim
Jhingook
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D001980:Bronchi / Q000601:surgery*; D001982:Bronchial Diseases / Q000401:mortality* / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D003251:Constriction, Pathologic / Q000401:mortality / Q000601:surgery; D005260:Female; D006801:Humans; D015994:Incidence; D007723:Korea / Q000453:epidemiology; D008168:Lung / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D019651:Plastic Surgery Procedures / Q000401:mortality*; D012189:Retrospective Studies; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D016879:Salvage Therapy / Q000401:mortality*; D016019:Survival Analysis; D015996:Survival Rate; D016896:Treatment Outcome